ApicHope Pharmaceutical Group Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Public

  • Employees
  • 1,294

Employees

  • Stock Symbol
  • 300723

Stock Symbol

  • Investments
  • 8

  • Share Price
  • $3.99
  • (As of Monday Closing)

ApicHope Pharmaceutical Group General Information

Description

ApicHope Pharmaceutical Group Co Ltd is engaged in Research and Development: pharmaceuticals; transfer of pharmaceutical technology; import and export of goods and technology; and leasing of non-residential real estate.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 17/F, Yunrun Building
  • No. 27, Huanyu 1st Road, Guangzhou International Biological Island, Huangpu District
  • Guangzhou, Guangdong 510320
  • China
+86 020
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
SHE
Vertical(s)
Corporate Office
  • 17/F, Yunrun Building
  • No. 27, Huanyu 1st Road, Guangzhou International Biological Island, Huangpu District
  • Guangzhou, Guangdong 510320
  • China
+86 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ApicHope Pharmaceutical Group Stock Performance

As of 16-Nov-2026, ApicHope Pharmaceutical Group’s stock price is $3.99. Its current market cap is $1.81B with 453M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.99 $4.23 $3.93 - $7.90 $1.81B 453M 5.67M $0.06

ApicHope Pharmaceutical Group Financials Summary

As of 30-Sep-2026, ApicHope Pharmaceutical Group has a trailing 12-month revenue of $107M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 2,374,688 2,374,913 1,208,134 1,989,094
Revenue 106,606 129,638 202,110 353,850
EBITDA 24,228 (14,327) (57,247) 63,935
Net Income 26,251 (46,973) (75,262) 26,094
Total Assets 643,697 577,735 603,294 621,462
Total Debt 301,025 296,286 231,621 113,200
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ApicHope Pharmaceutical Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ApicHope Pharmaceutical Group‘s full profile, request access.

Request a free trial

ApicHope Pharmaceutical Group Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ApicHope Pharmaceutical Group Investments & Acquisitions (8)

ApicHope Pharmaceutical Group’s most recent deal was a Later Stage VC with Degron Therapeutics for . The deal was made on 15-May-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Degron Therapeutics 15-May-2026 Later Stage VC Drug Discovery
Degron Therapeutics 29-Dec-2025 Later Stage VC Drug Discovery
South China Vaccine Corporation 17-Mar-2022 Later Stage VC Biotechnology
South China Vaccine Corporation 01-Jul-2021 Merger/Acquisition Biotechnology
South China Vaccine Corporation 01-Jul-2021 Secondary Transaction - Private Biotechnology
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

ApicHope Pharmaceutical Group ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

44.97 | Severe Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view ApicHope Pharmaceutical Group’s complete esg history, request access »

ApicHope Pharmaceutical Group Exits (1)

ApicHope Pharmaceutical Group’s most recent exit was on 23-Jun-2021 from Lyndra Therapeutics. The exit was categorized as with 12 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Lyndra Therapeutics 23-Jun-2021 Completed
  • 12 buyers
To view ApicHope Pharmaceutical Group’s complete exits history, request access »

ApicHope Pharmaceutical Group Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
South China Vaccine Corporation Guangzhou, China 2011

ApicHope Pharmaceutical Group FAQs

  • When was ApicHope Pharmaceutical Group founded?

    ApicHope Pharmaceutical Group was founded in 2002.

  • Where is ApicHope Pharmaceutical Group headquartered?

    ApicHope Pharmaceutical Group is headquartered in Guangzhou, China.

  • What is the size of ApicHope Pharmaceutical Group?

    ApicHope Pharmaceutical Group has 1,294 total employees.

  • What industry is ApicHope Pharmaceutical Group in?

    ApicHope Pharmaceutical Group’s primary industry is Pharmaceuticals.

  • Is ApicHope Pharmaceutical Group a private or public company?

    ApicHope Pharmaceutical Group is a Public company.

  • What is ApicHope Pharmaceutical Group’s stock symbol?

    The ticker symbol for ApicHope Pharmaceutical Group is 300723.

  • What is the current stock price of ApicHope Pharmaceutical Group?

    As of 16-Nov-2026 the stock price of ApicHope Pharmaceutical Group is $3.99.

  • What is the current market cap of ApicHope Pharmaceutical Group?

    The current market capitalization of ApicHope Pharmaceutical Group is $1.81B.

  • What is ApicHope Pharmaceutical Group’s current revenue?

    The trailing twelve month revenue for ApicHope Pharmaceutical Group is $107M.

  • What is ApicHope Pharmaceutical Group’s annual earnings per share (EPS)?

    ApicHope Pharmaceutical Group’s EPS for 12 months was $0.06.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process